Centre Asset Management Has Raised Raytheon Company (RTN) Position; Corcept Therapeutics (CORT) Had 4 Analysts Last Week

Among 4 analysts covering Corcept Therapeutics (NASDAQ:CORT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Corcept Therapeutics had 7 analyst reports since February 2, 2017 according to SRatingsIntel. On Thursday, February 2 the stock rating was initiated by Ladenburg Thalmann with “Buy”. On Thursday, August 24 the stock rating was maintained by Piper Jaffray with “Buy”. Piper Jaffray maintained Corcept Therapeutics Incorporated (NASDAQ:CORT) on Friday, September 8 with “Buy” rating. As per Friday, November 3, the company rating was maintained by Stifel Nicolaus. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, October 11. See Corcept Therapeutics Incorporated (NASDAQ:CORT) latest ratings:

03/11/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $25.0 Maintain
11/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $24.0 Maintain
08/09/2017 Broker: Piper Jaffray Rating: Buy New Target: $24.0 Maintain
31/08/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $20 Initiates Coverage On
24/08/2017 Broker: Piper Jaffray Rating: Buy New Target: $18.0 Maintain

Centre Asset Management Llc increased Raytheon Company (RTN) stake by 8.24% reported in 2017Q3 SEC filing. Centre Asset Management Llc acquired 3,550 shares as Raytheon Company (RTN)’s stock rose 4.85%. The Centre Asset Management Llc holds 46,650 shares with $8.70M value, up from 43,100 last quarter. Raytheon Company now has $58.64 billion valuation. The stock increased 2.40% or $4.75 during the last trading session, reaching $202.84. About 3.01M shares traded or 115.83% up from the average. Raytheon Company (NYSE:RTN) has risen 24.03% since January 26, 2017 and is uptrending. It has outperformed by 7.33% the S&P500.

Since December 8, 2017, it had 0 buys, and 2 selling transactions for $283,125 activity. The insider FISHMAN ROBERT S sold $149,349.

The stock decreased 0.08% or $0.02 during the last trading session, reaching $25.06. About 1.74 million shares traded. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 124.81% since January 26, 2017 and is uptrending. It has outperformed by 108.11% the S&P500.

Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company has market cap of $2.86 billion. It offers Korlym tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It has a 86.41 P/E ratio. The firm is also developing Korlym in combination with eribulin, which is in Phase I/II clinical trial to treat patients with metastatic triple-negative breast cancer; Korlym in combination with drug Abraxane that is in Phase II clinical trial to treat patients with triple-negative breast cancer; and Korlym combined with the androgen deprivation agent enzalutamide, which is in Phase II clinical trial to treat patients with metastatic castration-resistant prostate cancer.

Investors sentiment decreased to 1.96 in 2017 Q3. Its down 0.47, from 2.43 in 2017Q2. It dropped, as 13 investors sold Corcept Therapeutics Incorporated shares while 39 reduced holdings. 47 funds opened positions while 55 raised stakes. 71.96 million shares or 6.38% more from 67.64 million shares in 2017Q2 were reported. Numeric Invsts Lc reported 361,413 shares. Investor Ab invested in 0.93% or 750,423 shares. Art Llc owns 129,914 shares or 0.13% of their US portfolio. Moreover, Timpani Llc has 1.22% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT). Royal Natl Bank Of Canada stated it has 26,183 shares. Jpmorgan Chase & Company has 4,136 shares. Matarin Cap Mngmt Limited Liability Com holds 20,832 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Management Corporation invested in 0% or 22,700 shares. Usa Financial Portformulas Corp holds 34,091 shares. Bogle Inv Mgmt L P De reported 688,932 shares. Prelude Capital Ltd Liability owns 32,349 shares for 0.06% of their portfolio. Lpl Fincl Llc holds 51,258 shares or 0% of its portfolio. Blume Capital Management has invested 0.01% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). Swiss Bank stated it has 138,700 shares. Shaker Investments Limited Liability Oh holds 1.53% or 114,085 shares in its portfolio.

Since August 14, 2017, it had 0 insider buys, and 4 insider sales for $1.08 million activity. 650 shares were sold by Jimenez Frank R, worth $121,723 on Monday, October 2. The insider Clark Vernon E sold 829 shares worth $149,378. Long Letitia A had sold 650 shares worth $120,790. Lawrence Taylor W had sold 3,791 shares worth $690,304.

Investors sentiment increased to 1.21 in 2017 Q3. Its up 0.09, from 1.12 in 2017Q2. It is positive, as 42 investors sold RTN shares while 343 reduced holdings. 118 funds opened positions while 346 raised stakes. 205.51 million shares or 1.55% less from 208.75 million shares in 2017Q2 were reported. Shine Investment Advisory Serv Inc invested 0.07% in Raytheon Company (NYSE:RTN). Cambridge Tru Company has 7,558 shares. Bnp Paribas Asset Mgmt Sa has invested 0.66% in Raytheon Company (NYSE:RTN). Farmers Tru stated it has 1.04% of its portfolio in Raytheon Company (NYSE:RTN). Nwq Inv holds 365,427 shares or 0.83% of its portfolio. Old Second Bank Of Aurora reported 200 shares. Hanson Mcclain reported 100 shares or 0% of all its holdings. Endurance Wealth holds 1,155 shares or 0.04% of its portfolio. 42,275 are held by Novare Mgmt Ltd Llc. Cibc Asset stated it has 0.03% of its portfolio in Raytheon Company (NYSE:RTN). New England Private Wealth Advsrs Lc has 3,867 shares. Private Capital Advsr invested in 46,933 shares. St Johns Mgmt Company Llc owns 0.05% invested in Raytheon Company (NYSE:RTN) for 400 shares. Thompson Davis Com reported 0.69% of its portfolio in Raytheon Company (NYSE:RTN). Commonwealth Equity Svcs Incorporated reported 100,129 shares.